News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Biocontrol Spins Off Epilepsy Treatment Unit; Will Keep its Heart Attack Treatment Business
June 14, 2011
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Medical devices company BioControl Medical Ltd. will spin off its epilepsy treatment business into a new company, Cerebral RX Ltd. BioControl will keep its heart attack treatment business.
Twitter
LinkedIn
Facebook
Email
Print
Startups
Europe
MORE ON THIS TOPIC
Layoff Tracker
CAR T therapy developer Autolus laying off 13% of workforce
April 30, 2026
·
47 min read
·
BioSpace Editorial Staff
IPO tracker
Avalyn beats expectations with $300M debut
April 30, 2026
·
11 min read
·
Editorial Team
Earnings
Lilly clocks 56% revenue increase in Q1 but declining prices stunt growth
April 30, 2026
·
2 min read
·
Annalee Armstrong
Pipeline
AstraZeneca prunes asthma, rare disease pipeline, cultivates cancer portfolio
April 30, 2026
·
2 min read
·
Tristan Manalac